Physiological Finding in Management of COVID 19 Patients
ConditionCOVID-19 (Coronavirus Disease 2019)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSt. Martin De Porress Hospital
About this trial
This study utilizes physiological indicators of COVID-19 patients as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. This study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Reviewing the patient's medical history, the primary focus was on hospital records and existing physiological parameters such as blood pressure, heart rate, respiratory rate, and level of consciousness. The patient received treatment at the hospital between May 2022 and March 2027
Disqualifiers
Excluding patients with incomplete clinical data or missing information in their medical records.
Trial population
The COVID-19 patient received treatment at the hospital between May 2022 and March 2027 from emergency room, OPD
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
physiological parameters
Other interventionsystolic blood pressure, diastolic blood pressure , heart rate, respiratory rate , GCS
Treatment groups
15,000 Participants
are divided into 1 treatment groupGroup A: COVID-19 patient1 intervention
Trial outcomes
Primary outcomes
1
Shock index(SI) in the management of COVID -19
SI= heart rate / systolic blood pressre
Time frame
2022 May to 2027 March2
Mordified shock index(MSI) in the management of COVID -19
MSI=heart rate / mean arterial pressure
Time frame
2022 May to 2027 March3
Age shock index(Age SI) in the management of COVID -19
Age shock index =Age x (heart rate / systolic blood pression)
Time frame
2022 May to 2027 March4
Respiratory adjusted shock index (RASI) in the management of COVID-19
Respiratory adjusted shock index =(heart rate/systolic blood pression) x (repiratory rate/10)
Time frame
2022 may to 2027 MarchSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov